Daniel from Improve Press
Chicago-based GE HealthCare introduced it closed its acquisition of AI and imaging options firm MIM Software program, increasing its digital imaging choices.
Cleveland-based MIM Software program supplies distant software program options for oncology, nuclear medication, cardiac imaging and neuroimaging.
The corporate touts its merchandise as lowering time spent on handbook duties, permitting clinicians to deal with offering most cancers care to sufferers. MIM, or Medical Picture Merge, launched in 2003 as an imaging product for manipulating and studying DICOM photos.
MIM Software program choices shall be bought below the GE HealthCare model, together with MIM SurePlan, MIM Symphony and MIM Maestro.
Monetary particulars concerning the deal weren’t disclosed; nonetheless, GE HealthCare mentioned in a press release that the transaction was accomplished with money readily available.
“We’re thrilled to welcome MIM Software program, recognized for driving innovation in multimodal picture analytics and workflow, to our world GE HealthCare staff. These new capabilities align with our precision care technique to personalize care, improve hospital effectivity and clinician effectiveness, and attraction to new and current GE HealthCare and MIM Software program customers who see this as a chance to higher serve sufferers and assist enhance outcomes,” relayed Peter Arduini, president and CEO of GE HealthCare, in a press release.
THE LARGER TREND
MIM Software program first obtained FDA clearance for its cellular MIM radiology app in 2011. The app permits distant viewing of high-resolution X-ray and ultrasound photos downloaded from a cloud-based service. Within the app’s newest model, suppliers can view dose-volume histograms, isodose curves, and pictures for therapy plans.
In December, the imaging firm introduced it secured FDA clearance for Contour ProtegeAI+, an automated auto-contouring device that reduces handbook contouring processes and permits extra time to create most cancers therapy plans.
MIM is GE HealthCare’s third acquisition as an impartial firm. The corporate acquired CT interventional steering firm IMACTIS in 2023 and AI ultrasound producer Caption Well being.
GE HealthCare has secured a number of FDA clearances because it was spun out of GE in early 2023.
The identical yr, the corporate obtained FDA clearance for Precision DL, aimed to enhance screening time, picture high quality and small lesion detection, and clearance for a tool the scale of a smartphone known as Portrait Cell for monitoring affected person respiration charges remotely.
In February, GE HealthCare scored FDA clearance for Novii+, a maternal and fetal monitoring platform for high-risk being pregnant.
The corporate lately introduced its Brazilian-based companion Ionic Well being secured FDA clearance for its distant imaging software program, which supplies diagnostic imaging facilities with real-time scanning, distant steering and operational help, and the power to view/overview photos remotely.
